Physician profile
Matthew R Levasseur
NPI 1477059921
$9,838.89
in general payments reported to CMS, 2019-2025
10 companies · $6,824 in 2025
The $6,824 reported for 2025 was more than what 85% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,200 · 2024: $1,815 · 2025: $6,824.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,125 · Travel and Lodging: $3,014 · Consulting Fee: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,125.22 |
| Travel and Lodging | $3,013.67 |
| Consulting Fee | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, Lp | $3,390.99 | 2024-2025 | Djo Surgical |
| Zimmer Biomet Holdings, INC. | $2,090.16 | 2024-2025 | Comprehensive Shoulder System, Osseofit, Identity |
| Kairos Surgical INC | $1,200.00 | 2022 | |
| Exactech, INC. | $987.90 | 2025 | |
| Medical Device Business Services, INC. | $611.07 | 2025 | Healix Knotless Peek |
| Stryker Corporation | $455.96 | 2024-2025 | Aequalis Perform, Mako, Axsos |
| Prodigy Surgical Distribution, INC. | $381.17 | 2025 | |
| Linvatec Corporation | $279.02 | 2025 | Biobrace 23mm |
| Gotham Surgical Solutions & Devices, INC. | $268.59 | 2024-2025 | |
| Smith+Nephew, INC. | $174.03 | 2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Levasseur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.